| NOBEL Pharma Schweiz AG - Eltrombopag NOBEL 12.5 mg, Filmtabletten | | 69450 | | 01 | | Eltrombopag NOBEL 12.5 mg | | Filmtabletten | | B02BX05 | | Eltrombopag | | 28.08.2024 | | |
| | Composition | | eltrombopagum 12.5 mg ut eltrombopagum olaminum, cellulosum microcristallinum, mannitolum, povidonum K 30, cellulosum microcristallinum silicificatum, carboxymethylamylum natricum A, glyceroli dibehenas, magnesii stearas, Überzug: titanii dioxidum, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 3.621 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Eltrombopagum | 12.5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | Cellulosum Microcristallinum Silicificatum | | | | Glyceroli Dibehenas | | | | Hypromellosum | | | | Macrogol | 400 | | | Magnesii Stearas | | | | Mannitol | | | | Polysorbatum 80 | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Titanium Dioxide | | Überzug |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 14 | PR | PR | A | | No |
|
|
